Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer
The purpose of this study is to observe quality of life and treatment side effects in patients with advanced non small cell lung cancer (NSCLC) receive chemotherapy and Yangzhengxiaoji capsule.
Non-Small Cell Lung Cancer
DRUG: Yangzhengxiaoji Capsule|DRUG: Placebo Capsule
Functional Assessment of Cancer Therapy-Lung scale, 84day|Lung Cancer Symptom Scale, 84day
Anti-cancer drugs common grading evaluation of adverse reaction, 84day|Completion of chemotherapy, 84 day|Objective response rate, 84day|Progression-free survival, 84 day
The purpose of this study is to observe quality of life and treatment side effects in patients with advanced non small cell lung cancer (NSCLC) receive chemotherapy and Yangzhengxiaoji capsule.